세계의 주사제 포장 및 성분 시장 규모 : 포장재별, 비경구제별, 성분별, 용량별, 지역별, 범위 및 전망

Injectable Packaging And Component Market Size And Forecast

Injectable Packaging And Component Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.

Injectable drug packaging so that its constituents do not intrude with external environmental parameters. There are vials, cartridges, prefilled syringes, seals, as well as other injectable packaging and component product lines. The pharmaceutical industry's growth is fueled by increased medication use, a greater emphasis on personalized medicine, and the beginnings of new therapeutics for chronic health conditions. The Global Injectable Packaging And Component Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Injectable Packaging And Component Market Definition

Injectable packaging implicates filling and sealing drugs and components in a single compact machine frame, removing several of the steps and extra costs associated with conventional processing. Weight savings, particle-free processing, resistance to breakage, ease of opening, and recycling capacity differentiate injectable packaging from glass. Injectable drugs are more complicated than oral medications and can easily interact with environmental exposures. As an outcome, any container that makes contact with the active substance is demonstrated to not influence the drug. Injectable drug packaging is done in a way that its components do not interfere with outside environmental parameters.

Vials, cartridges and prefilled syringes, seals, as well as other injectable packaging and component products, are available. The Injectable Packaging and Components are classified as Vials, Seals, Cartridges, Syringes, Ampules, and Other. A vial is a small container that is generally made of plastic or glass. Unlike standard blood collection tubes, it is shaped like a tube or bottle and has a flat bottom. Vials are usable with a variety of caps to meet specific storage or handling necessities. A cartridge is a container of a substance used in a syringe to administer to a patient.

Insert the cartridge into the syringe body opening. The medicine is enclosed in a cartridge within the metal syringe. Ampoules are perfect for storing unstable elements because the seal protects the chemical from contamination. To ensure that the drug remains stable, drugs companies extract air from the ampoule before inserting the drug. The packaging ensures protection of the product from all external factors that degrade its performance or potency, including light, humidity, oxygen, biological contamination, as well as counterfeiting.

Global Injectable Packaging And Component Market Overview

The focus on biopharmaceutical and pharmaceutical manufacturing core competencies and the need for companies to move, the cost of ownership, and the growing significance of components as part of a combination product are the four major developments fueling the development of injectable packaging and components demand for higher durability. Moreover, Higher use of medicines, a growing focus on personalized medicine, and the rise of innovative therapies for chronic conditions are driving pharmaceutical industry growth.

The Injectable Packaging And Component Market is changing significantly as a result of the progression of the pharmaceutical and biotechnology industries, as well as developments in material science and manufacturing methods. The Global Injectable Packaging And Component Market is supported by growth such as the rising middle class in developing economies, the increasing share of injectables in the drug pipeline, a rise in cancer incidence, etc.

Furthermore, Pharmaceutical packaging essentials are influenced by using the increasing need for patient self-management and the increasing variety of natural therapies, including cell and gene therapies, as well as cutting-edge developments in COVID-19 vaccines leading to drive the overall growth of the market. Oral solid dosage forms completely dominate the market, and injectable medicines are increasing at a high rate. Nonetheless, the market's growth is hampered by strict laws and restrictions governing drug packaging.

With rising regulatory requirements and the prominence of patient safety, the current Injectable Packaging And Component Market is facing problems to bring this product to the market as quickly and effectively as possible leading to hindering the Global Injectable Packaging and Component Market. As new technology progresses stability, sterility, and shelf life over the glass, pharmaceutical companies are switching toward flexible structures for packaging injectable medicinal products leading to a rise in the growth of the market throughout the projected period.

Global Injectable Packaging And Component Market Segmentation Analysis

The Global Injectable Packaging And Component Market is Segmented on the basis of Packaging Material, Parenteral, Component, Dosage, And Geography.

Injectable Packaging And Component Market, By Packaging Material

• Glass
• Metal

Based on Packaging Material, The market is segmented into Glass and Metal. Glass has the highest growing segment of the Global Injectable Packaging and Components Market. Because of its high transparency, its contents are easily monitored. And it is highly resistive to air and moisture, it provides better protection as compared to metal over the projected period.

Injectable Packaging And Component Market, By Parenteral

• Small Volume Parenteral
• Large Volume Parenteral

Based on Parenteral, The market is segmented into Small Volume Parenteral and Large Volume Parenteral. The Small Volume Parenteral has the highest growing segment of the Global Injectable Packaging and Components Market. To establish specific parameters, establish drug quality, and maintain the drug's shelf life as compared to the large volume parenteral over the forecasted period.

Injectable Packaging And Component Market, By Component

• Cartridges
• Ampules
• Vials
• Syringes
• Seals
• Other

Based on Component, The market is segmented into Cartridges, Ampules, Vials, Syringes, Seals, Other. Vials have the largest growing segment of the Global Injectable Packaging and Components Market. The most common packaging material for liquid and freeze-dried injectables is glass vials. Plastic vials are less frequently used due to the ease with which glass is sterilized and transferred to aseptic environments over the projected period.

Injectable Packaging And Component Market, By Dosage

• Single Dosage
• Multi Dosage

Based on Dosage, The market is segmented into Single Dosage and Multi Dosage. A Single-Dose has the largest growing segment of the Global Injectable Packaging and Components Market A single dosage of a parenteral preparation that does not need to be tested for antimicrobial efficacy. A single dosage is designed to be used with a single patient for a single injection leading to an increase in the growth of the market globally.

Injectable Packaging And Component Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Injectable Packaging And Component Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the highest growing segment of the Global Injectable Packaging and Components Market. Factors include the rising incidence of chronic diseases, the growth of the Injectable Packaging And Component Market, and the increasing demands for self-injection devices over the forecasted period.

Key Players

• The "Global Injectable Packaging And Component Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
• West Pharmaceutical Services, Inc., Gerresheimer AG, Actiza Pharmaceutical Private Limited. Ypsomed Group, Injectapak, Pace Biotech, Aptar Pharma, and Datwyler Holding Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET

• 1.1. Overview of the Market
• 1.2. Scope of Report
• 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1. Data Mining
• 3.2. Validation
• 3.3. Primary Interviews
• 3.4. List of Data Sources

4. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET OUTLOOK

• 4.1. Overview
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. Porters Five Force Model
• 4.4. Value Chain Analysis

5. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PACKAGING MATERIAL

• 5.1. Overview
• 5.2. Glass
• 5.3. Metal

6. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PARENTERAL

• 6.1. Overview
• 6.2. Small Volume Parenteral
• 6.3. Large Volume Parenteral

7. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY COMPONENT

• 7.1. Overview
• 7.2. Cartridges
• 7.3. Syringes
• 7.4. Vials
• 7.5. Ampules
• 7.6. Seals
• 7.7. Other

8. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY DOSAGE

• 8.1. Overview
• 8.2. Single Dosage
• 8.3. Multi Dosage

9. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.3 Canada
  • 9.2.4 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East and Africa

10. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET COMPETITIVE LANDSCAPE

• 10.1. Overview
• 10.2. Company Market Ranking
• 10.3. Key Development Strategies

11. COMPANY PROFILES

• 11.1 West Pharmaceutical Services
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Gerresheimer AG
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Actiza Pharmaceutical Private Limited
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 Ypsomed Group
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.5 Datwyler Holding Inc.
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Injectapak
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Pace Biotech
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 Aptar Pharma
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments

12. Appendix

• 12.1. Related Research